Facility is a part of LakePharma's GMP microBiomanufacturing Center, which began operations last month and is currently producing GMP-grade plasmid DNA
Gains licenses for manufacture, downstream processing into capsules and tablets, as well as spray dried formulations of biotherapeutics and small molecule APIs
The agreement now covers Accord’s European Solid Dose Products, including those in the central nervous system, autoimmune, diabetes and anti-viral therapy areas